TY - JOUR AU - Karre, K. AU - Ljunggren, H. G. AU - Piontek, G. AU - Kiessling, R. PY - 1986 DA - 1986// TI - Selective rejection of H−2-deficient lymphoma variants suggests alternative immune defence strategy JO - Nature VL - 319 UR - https://doi.org/10.1038/319675a0 DO - 10.1038/319675a0 ID - Karre1986 ER - TY - JOUR AU - Smyth, M. J. AU - Kelly, J. M. AU - Baxter, A. G. AU - Korner, H. AU - Sedgwick, J. D. PY - 1998 DA - 1998// TI - An essential role for tumor necrosis factor in natural killer cell-mediated tumor rejection in the peritoneum JO - J Exp Med VL - 188 UR - https://doi.org/10.1084/jem.188.9.1611 DO - 10.1084/jem.188.9.1611 ID - Smyth1998 ER - TY - JOUR AU - Garrido, F. AU - Aptsiauri, N. AU - Doorduijn, E. M. AU - Garcia Lora, A. M. AU - van Hall, T. PY - 2016 DA - 2016// TI - The urgent need to recover MHC class I in cancers for effective immunotherapy JO - Curr Opin Immunol VL - 39 UR - https://doi.org/10.1016/j.coi.2015.12.007 DO - 10.1016/j.coi.2015.12.007 ID - Garrido2016 ER - TY - JOUR AU - Brentjens, R. J. AU - Davila, M. L. AU - Riviere, I. AU - Park, J. AU - Wang, X. AU - Cowell, L. G. AU - Bartido, S. AU - Stefanski, J. AU - Taylor, C. AU - Olszewska, M. PY - 2013 DA - 2013// TI - CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia JO - Sci Transl Med VL - 5 UR - https://doi.org/10.1126/scitranslmed.3005930 DO - 10.1126/scitranslmed.3005930 ID - Brentjens2013 ER - TY - JOUR AU - Rosenberg, S. A. AU - Restifo, N. P. PY - 2015 DA - 2015// TI - Adoptive cell transfer as personalized immunotherapy for human cancer JO - Science VL - 348 UR - https://doi.org/10.1126/science.aaa4967 DO - 10.1126/science.aaa4967 ID - Rosenberg2015 ER - TY - JOUR AU - Klingemann, H. AU - Boissel, L. AU - Toneguzzo, F. PY - 2016 DA - 2016// TI - Natural killer cells for immunotherapy - advantages of the NK-92 cell line over blood NK cells JO - Front Immunol VL - 7 UR - https://doi.org/10.3389/fimmu.2016.00091 DO - 10.3389/fimmu.2016.00091 ID - Klingemann2016 ER - TY - JOUR AU - Gong, J. H. AU - Maki, G. AU - Klingemann, H. G. PY - 1994 DA - 1994// TI - Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells JO - Leukemia VL - 8 ID - Gong1994 ER - TY - JOUR AU - Tonn, T. AU - Schwabe, D. AU - Klingemann, H. G. AU - Becker, S. AU - Esser, R. AU - Koehl, U. AU - Suttorp, M. AU - Seifried, E. AU - Ottmann, O. G. AU - Bug, G. PY - 2013 DA - 2013// TI - Treatment of patients with advanced cancer with the natural killer cell line NK-92 JO - Cytotherapy VL - 15 UR - https://doi.org/10.1016/j.jcyt.2013.06.017 DO - 10.1016/j.jcyt.2013.06.017 ID - Tonn2013 ER - TY - JOUR AU - Jochems, C. AU - Hodge, J. W. AU - Fantini, M. AU - Fujii, R. AU - Morillon, Y. M. AU - Greiner, J. W. AU - Padget, M. R. AU - Tritsch, S. R. AU - Tsang, K. Y. AU - Campbell, K. S. PY - 2016 DA - 2016// TI - An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 allele JO - Oncotarget VL - 7 ID - Jochems2016 ER - TY - JOUR AU - Jochems, C. AU - Hodge, J. W. AU - Fantini, M. AU - Tsang, K. Y. AU - Vandeveer, A. J. AU - Gulley, J. L. AU - Schlom, J. PY - 2017 DA - 2017// TI - ADCC employing an NK cell line (haNK) expressing the high affinity CD16 allele with avelumab, an anti-PD-L1 antibody JO - Int J Cancer VL - 141 UR - https://doi.org/10.1002/ijc.30767 DO - 10.1002/ijc.30767 ID - Jochems2017 ER - TY - JOUR AU - Davis, R. J. AU - Van Waes, C. AU - Allen, C. T. PY - 2016 DA - 2016// TI - Overcoming barriers to effective immunotherapy: MDSCs, TAMs, and Tregs as mediators of the immunosuppressive microenvironment in head and neck cancer JO - Oral Oncol VL - 58 UR - https://doi.org/10.1016/j.oraloncology.2016.05.002 DO - 10.1016/j.oraloncology.2016.05.002 ID - Davis2016 ER - TY - JOUR AU - Chen, G. AU - Shi, L. AU - Litchfield, D. W. AU - Greenberg, A. H. PY - 1995 DA - 1995// TI - Rescue from granzyme B-induced apoptosis by Wee1 kinase JO - J Exp Med VL - 181 UR - https://doi.org/10.1084/jem.181.6.2295 DO - 10.1084/jem.181.6.2295 ID - Chen1995 ER - TY - JOUR AU - Castedo, M. AU - Perfettini, J. L. AU - Roumier, T. AU - Andreau, K. AU - Medema, R. AU - Kroemer, G. PY - 2004 DA - 2004// TI - Cell death by mitotic catastrophe: a molecular definition JO - Oncogene VL - 23 UR - https://doi.org/10.1038/sj.onc.1207528 DO - 10.1038/sj.onc.1207528 ID - Castedo2004 ER - TY - JOUR AU - Vitale, I. AU - Galluzzi, L. AU - Castedo, M. AU - Kroemer, G. PY - 2011 DA - 2011// TI - Mitotic catastrophe: a mechanism for avoiding genomic instability JO - Nat Rev Mol Cell Biol VL - 12 UR - https://doi.org/10.1038/nrm3115 DO - 10.1038/nrm3115 ID - Vitale2011 ER - TY - JOUR AU - DeHart, S. L. AU - Heikens, M. J. AU - Tsai, S. PY - 2005 DA - 2005// TI - Jagged2 promotes the development of natural killer cells and the establishment of functional natural killer cell lines JO - Blood VL - 105 UR - https://doi.org/10.1182/blood-2004-11-4237 DO - 10.1182/blood-2004-11-4237 ID - DeHart2005 ER - TY - JOUR AU - Cash, H. AU - Shah, S. AU - Moore, E. AU - Caruso, A. AU - Uppaluri, R. AU - Van Waes, C. AU - Allen, C. PY - 2015 DA - 2015// TI - mTOR and MEK1/2 inhibition differentially modulate tumor growth and the immune microenvironment in syngeneic models of oral cavity cancer JO - Oncotarget VL - 6 UR - https://doi.org/10.18632/oncotarget.5063 DO - 10.18632/oncotarget.5063 ID - Cash2015 ER - TY - JOUR AU - Brenner, J. C. AU - Graham, M. P. AU - Kumar, B. AU - Saunders, L. M. AU - Kupfer, R. AU - Lyons, R. H. AU - Bradford, C. R. AU - Carey, T. E. PY - 2010 DA - 2010// TI - Genotyping of 73 UM-SCC head and neck squamous cell carcinoma cell lines JO - Head Neck VL - 32 ID - Brenner2010 ER - TY - STD TI - Moore E, Clavijo PE, Davis R, Cash H, Van Waes C, Kim Y, Allen C. Established T cell-inflamed tumors rejected after adaptive resistance was reversed by combination STING activation and PD-1 pathway blockade. Cancer Immunol Res. 2016;4:1061–1071. ID - ref18 ER - TY - JOUR AU - Quah, B. J. AU - Warren, H. S. AU - Parish, C. R. PY - 2007 DA - 2007// TI - Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester JO - Nat Protoc VL - 2 UR - https://doi.org/10.1038/nprot.2007.296 DO - 10.1038/nprot.2007.296 ID - Quah2007 ER - TY - JOUR AU - Cuneo, K. C. AU - Morgan, M. A. AU - Davis, M. A. AU - Parcels, L. A. AU - Parcels, J. AU - Karnak, D. AU - Ryan, C. AU - Liu, N. AU - Maybaum, J. AU - Lawrence, T. S. PY - 2016 DA - 2016// TI - Wee1 kinase inhibitor AZD1775 Radiosensitizes hepatocellular carcinoma regardless of TP53 mutational status through induction of replication stress JO - Int J Radiat Oncol Biol Phys VL - 95 UR - https://doi.org/10.1016/j.ijrobp.2016.01.028 DO - 10.1016/j.ijrobp.2016.01.028 ID - Cuneo2016 ER - TY - JOUR AU - Hirai, H. AU - Iwasawa, Y. AU - Okada, M. AU - Arai, T. AU - Nishibata, T. AU - Kobayashi, M. AU - Kimura, T. AU - Kaneko, N. AU - Ohtani, J. AU - Yamanaka, K. PY - 2009 DA - 2009// TI - Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agents JO - Mol Cancer Ther VL - 8 UR - https://doi.org/10.1158/1535-7163.MCT-09-0463 DO - 10.1158/1535-7163.MCT-09-0463 ID - Hirai2009 ER - TY - JOUR AU - Clavijo, P. E. AU - Moore, E. C. AU - Chen, J. AU - Davis, R. J. AU - Friedman, J. AU - Kim, Y. AU - Van Waes, C. AU - Chen, Z. AU - Allen, C. T. PY - 2017 DA - 2017// TI - Resistance to CTLA-4 checkpoint inhibition reversed through selective elimination of granulocytic myeloid cells JO - Oncotarget VL - 8 UR - https://doi.org/10.18632/oncotarget.18437 DO - 10.18632/oncotarget.18437 ID - Clavijo2017 ER - TY - JOUR AU - Judd, N. P. AU - Winkler, A. E. AU - Murillo-Sauca, O. AU - Brotman, J. J. AU - Law, J. H. AU - Lewis, J. S. AU - Dunn, G. P. AU - Bui, J. D. AU - Sunwoo, J. B. AU - Uppaluri, R. PY - 2012 DA - 2012// TI - ERK1/2 regulation of CD44 modulates oral cancer aggressiveness JO - Cancer Res VL - 72 UR - https://doi.org/10.1158/0008-5472.CAN-11-1831 DO - 10.1158/0008-5472.CAN-11-1831 ID - Judd2012 ER - TY - JOUR AU - Davis, R. J. AU - Moore, E. C. AU - Clavijo, P. E. AU - Friedman, J. AU - Cash, H. AU - Chen, Z. AU - Silvin, C. AU - Van Waes, C. AU - Allen, C. PY - 2017 DA - 2017// TI - Anti-PD-L1 efficacy can be enhanced by inhibition of myeloid-derived suppressor cells with a selective inhibitor of PI3Kdelta/gamma JO - Cancer Res VL - 77 UR - https://doi.org/10.1158/0008-5472.CAN-16-2534 DO - 10.1158/0008-5472.CAN-16-2534 ID - Davis2017 ER - TY - JOUR AU - Do, K. AU - Wilsker, D. AU - Ji, J. AU - Zlott, J. AU - Freshwater, T. AU - Kinders, R. J. AU - Collins, J. AU - Chen, A. P. AU - Doroshow, J. H. AU - Kummar, S. PY - 2015 DA - 2015// TI - Phase I study of single-agent AZD1775 (MK-1775), a Wee1 kinase inhibitor, in patients with refractory solid tumors JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2014.60.4009 DO - 10.1200/JCO.2014.60.4009 ID - Do2015 ER - TY - JOUR AU - De Witt Hamer, P. C. AU - Mir, S. E. AU - Noske, D. AU - Van Noorden, C. J. AU - Wurdinger, T. PY - 2011 DA - 2011// TI - WEE1 kinase targeting combined with DNA-damaging cancer therapy catalyzes mitotic catastrophe JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-10-2537 DO - 10.1158/1078-0432.CCR-10-2537 ID - De Witt Hamer2011 ER - TY - STD TI - Parsels LA, Karnak D, Parsels JD, Zhang Q, Velez-Padilla J, Reichert ZR, Wahl DR, Maybaum J, O'Connor MJ, Lawrence TS, Morgan MA. PARP1 trapping and DNA replication stress enhance Radiosensitization with combined WEE1 and PARP inhibitors. Mol Cancer Res. 2017;16:222–232. ID - ref27 ER - TY - JOUR AU - Parker, L. L. AU - Piwnica-Worms, H. PY - 1992 DA - 1992// TI - Inactivation of the p34cdc2-cyclin B complex by the human WEE1 tyrosine kinase JO - Science VL - 257 UR - https://doi.org/10.1126/science.1384126 DO - 10.1126/science.1384126 ID - Parker1992 ER - TY - JOUR AU - Hayakawa, Y. AU - Kelly, J. M. AU - Westwood, J. A. AU - Darcy, P. K. AU - Diefenbach, A. AU - Raulet, D. AU - Smyth, M. J. PY - 2002 DA - 2002// TI - Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin JO - J Immunol VL - 169 UR - https://doi.org/10.4049/jimmunol.169.10.5377 DO - 10.4049/jimmunol.169.10.5377 ID - Hayakawa2002 ER - TY - JOUR AU - Diefenbach, A. AU - Jensen, E. R. AU - Jamieson, A. M. AU - Raulet, D. H. PY - 2001 DA - 2001// TI - Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity JO - Nature VL - 413 UR - https://doi.org/10.1038/35093109 DO - 10.1038/35093109 ID - Diefenbach2001 ER - TY - JOUR AU - Onken, M. D. AU - Winkler, A. E. AU - Kanchi, K. L. AU - Chalivendra, V. AU - Law, J. H. AU - Rickert, C. G. AU - Kallogjeri, D. AU - Judd, N. P. AU - Dunn, G. P. AU - Piccirillo, J. F. PY - 2014 DA - 2014// TI - A surprising cross-species conservation in the genomic landscape of mouse and human oral cancer identifies a transcriptional signature predicting metastatic disease JO - Clin Cancer Res VL - 20 UR - https://doi.org/10.1158/1078-0432.CCR-14-0205 DO - 10.1158/1078-0432.CCR-14-0205 ID - Onken2014 ER - TY - JOUR AU - Moore, E. C. AU - Cash, H. A. AU - Caruso, A. M. AU - Uppaluri, R. AU - Hodge, J. W. AU - Van Waes, C. AU - Allen, C. T. PY - 2016 DA - 2016// TI - Enhanced tumor control with combination mTOR and PD-L1 inhibition in syngeneic oral cavity cancers JO - Cancer Immunol Res VL - 4 UR - https://doi.org/10.1158/2326-6066.CIR-15-0252 DO - 10.1158/2326-6066.CIR-15-0252 ID - Moore2016 ER - TY - JOUR AU - Shah, N. N. AU - Baird, K. AU - Delbrook, C. P. AU - Fleisher, T. A. AU - Kohler, M. E. AU - Rampertaap, S. AU - Lemberg, K. AU - Hurley, C. K. AU - Kleiner, D. E. AU - Merchant, M. S. PY - 2015 DA - 2015// TI - Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell-depleted stem cell transplantation JO - Blood VL - 125 UR - https://doi.org/10.1182/blood-2014-07-592881 DO - 10.1182/blood-2014-07-592881 ID - Shah2015 ER -